|
Jul 29
|
Could The Market Be Wrong About ResMed Inc. (NYSE:RMD) Given Its Attractive Financial Prospects?
|
|
Jul 29
|
Seeking Clues to ResMed (RMD) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
|
|
Jul 26
|
Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 25
|
ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth
|
|
Jun 26
|
Bruker's (BRKR) Strategic Buyouts Aid Amid Macroeconomic Woes
|
|
Jun 26
|
Boston Scientific (BSX) DBS Programming Software Gets CE Mark
|
|
Jun 25
|
Medtronic (MDT) Shares Positive Data for MiniMed 780G System
|
|
Jun 24
|
Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again
|
|
Jun 24
|
Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks
|
|
Jun 24
|
It's Not Just a Bad Day for Chip Stocks. ResMed Is the S&P 500’s Top Decliner.
|
|
Jun 24
|
How Lilly is joining Novo in the crusade to circumvent Medicare's block on weight loss drugs
|
|
Jun 24
|
ResMed Stock Dives. Blame Eli Lilly’s Zepbound Trials for Sleep Apnea.
|
|
Jun 24
|
Top Stock Movers Now: Affirm, Nvidia, ResMed, and More
|
|
Jun 24
|
Abbott's (ABT) EPD Expansion Continues Despite FX Headwind
|
|
Jun 24
|
Valneva's (VALN) CHIKV Vaccine Gets Health Canada's Approval
|
|
Jun 24
|
Why a Pair of Eli Lilly Clinical Trials Sent ResMed Stock Tumbling
|
|
Jun 24
|
Eli Lilly seeks to expand Zepbound use to treat sleep apnea
|
|
Jun 24
|
Best Momentum Stock to Buy for June 24th
|
|
Jun 24
|
Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes
|
|
Jun 24
|
ResMed Inc. (NYSE:RMD) Shares Could Be 24% Below Their Intrinsic Value Estimate
|